Serum-Free Media Market to Reach Valuation of US$ 660.4 Mn by 2031, Increase in Generic Population to Drive Market

Albany NY, United States: According to the report, the global serum-free media market was valued at US$ 320 Mn in 2020 and is projected to expand at a CAGR of 7% from 2021 to 2031.

Albany NY, United States: According to the report, the global serum-free media market was valued at US$ 320 Mn in 2020 and is projected to expand at a CAGR of 7% from 2021 to 2031. Serum-free media contains all the essential nutrients such as amino acids, carbohydrates, and lipids as in normal cell culture media, except serum. This type of media lacks various growth factors such as vascular epidermal growth factors (VEGF) and bone growth factors (BGF) that are essential for the normal growth of cells. Hence, serum-free media is called selectively optimized media, as it is selective for a particular type of cell culture.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74009

Serum-free media is used in various applications, major application being the production of recombinant therapeutic proteins. These are also used in suspension & adherent cultures for culturing hybridoma and various white blood cells. In terms of media type, the global serum-free media market has been classified into CHO cell media, protein expression media, immunology media, insect cell media, hybridoma media, stem cell media, and chemically defined media. The CHO cell media segment accounted for a significant share of the global serum-free media market in 2020.

Based on end-user, the global serum-free media market has been divided into biopharma industry, clinical research organizations, research centers, and others. The biopharma industry segment held a major share of the global serum-free media market in 2020.

Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74009

Serum-free Media Market: Prominent Regions

North America accounted for a major share of the global serum-free media market in 2020. Presence of key players, rise in number of chronic diseases that use serum-free media as culture for drug development processes, and growth strategies adopted by key players drive the serum-free media market in the region. Europe held the second largest share of the global serum-free media market in 2020. The growth of the market in the region can be attributed to well-developed healthcare infrastructure and increase in demand for various recombinant proteins and types of culture. The serum-free media market in Europe is likely to grow at a rapid pace during the forecast period. Technological developments in serum-free media are also likely to propel the serum-free media market in the region.

Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=74009

Serum-free Media Market: Key Players

Key players are expanding their footprint to consolidate their positions and increase their share in the global serum-free media market. Hence, manufacturers engage in new product development, collaborations, and distribution to gain market share. Leading players operating in the global serum-free media market include Thermo Fisher Scientific, Athena Environmental Sciences, Pan Biotech, Bichrom, Irvine Scientific, Biological Industries, Sigma-Aldrich, CellGenix, and HiMedia Laboratories.

Global Serum-free Media Market: Segmentation

Serum-free Media Market, by Media Type

  • CHO Cell Media
  • Protein Expression Media
  • Immunology Media
  • Insect Cell Media
  • Hybridoma Media
  • Stem Cell Media
  • Chemically Defined Media

Serum-free Media Market, by End-user

  • Biopharma Industry
  • Clinical Research Organizations
  • Research Centers
  • Others

More Trending Reports by Transparency Market Research:

Serum Biomarkers Market: Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.

Recombinant Human Serum Albumin Market: Human serum albumin (HSA) is responsible for a number of biological functions including binding and delivering molecules and substances to the cell. It also plays an important role as antioxidant and transporter of ligands. HSA is widely used in hospitals and clinics to treat a number of diseases such as hemorrhagic shock, hypoproteinemia, serious burn injuries, fetal erythroblastosis, and cirrhotic ascites.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/